Prot#1245.110: EMPORER - A phase III randomised, double-blind trial to evaluate efficacy and safety of once daily empagliflozin 10 mg compared to placebo, in patients with chronic Heart Failure with preserved Ejection Fraction (HFpEF)
- Khan, Sadiya Sana (PD/PI)
Project: Research project